| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Evp/ Chief Scientific Officer | Chief Scientific Officer
1 company
Albright Charles is an Evp/ Chief Scientific Officer at Editas Medicine, Inc.. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $84K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 3, 2020 | EDIT Editas Medicine, Inc. | Chief Scientific Officer | Sale+OE | 5,549 | $26.54 | $147,287.66 | -21.3% | |
| Jun 13, 2018 | EDIT Editas Medicine, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $35.98 | $359,800.00 | -100% | |
| May 23, 2018 | EDIT Editas Medicine, Inc. | Chief Scientific Officer | Sale+OE | 10,000 | $35.00 | $350,000.00 | -100% |